___

• 1. Linares MCU, Perez IR, Perez MJB, Lima AOL, Torres EH,Castano JP. Analyses of the impact of fibromyalgia on quality of life: associated factors. Clin Rheumatol 2007 Epub (URL:http:// www.springerlink.com/content/d42x385k34218611/) 2. Reiffenberger DH, Amundson LH. Fibromyalgia syndrome: a re- view. Am Fam Physician 1996; 53: 1698-1704. 3. Csillag C. Fibromyalgia: the Copenhagen Declaration. Lancet 1992; 340: 663-664. 4. Yunus MB, İnanıcı F, Aldag JC, Mangold RF. Fibromyalgia in men: comparison of clinical features with women. J Rheumatol. 2000; 27: 485-90. 5. Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hobo- ken). May 2013;65(5):786-92. 6. F. Wolfe,Aspects of the epidemiology of fibromyalgiaJ. Musculos- kel. Pain, 2 (1994), pp. 65–77 7. López-Pousa S, Garre-Olmo J, de Gracia M, Ribot J, Calvó-Perxas L, Vilalta-Franch J. Development of a multidimensional measu- re of fibromyalgia symptomatology: The comprehensive rating scale for fibromyalgia symptomatology. J Psychosom Res. May 2013;74(5):384-92 8. Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent proces- sing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011 Mar-Apr;14(2):E217-45. 9. Erçalik C, Fibromiyalji Sendromunda Bilişsel Davraniş Tedavisi Ve Tens Tedavilerinin Etkinliği Uzmanlik Tezi, 10. Kaşkari D. Fibromiyalji Tanisi Alan Hastalarda Spondiloartropati Sıklığı Yandal Uzmanlık Tezi Başkent Üniversitesi Tıp Fakültesi İç Hastaliklari Anabilim Dali Romatoloji Bilim Dali Ankara 2012 11. Goldenberg DL, Burckhardt C, Crofford L. Management of fib- romyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95. 12. Goldenberg DL. Psychiatric and psychologic aspects of fibromyal- gia syndrome. Rheum Dis Clin North Am 1989; 15: 105-14. 13. Granges G, Zilko P, Littlejohn GO. Fibromyalgia syndrome: As- sessment of the severity of the condition two years after diagnosis. J Rheumatol 1994; 21: 523-9. 14. http://emedicine.medscape.com/article/329838-differential Fibrom- yalgia Differential Diagnoses Author: Chad S Boomershine, MD, PhD; Chief Editor: Herbert S Diamond, MD , Updated: May 2, 2014 15. Bazzichi L, Rossi A, Zirafa C, Monzani F, Tognini S, Dardano A, Santini F,Tonacchera M, De Servi M, Giacomelli C, De Feo F, Do- veri M, Massimetti G,Bombardieri S. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int. 2012 Feb;32(2):335-41. 16. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014 Apr- May;13(4-5):391-7. 17. Aarflot T, Bruusgaard D. Association between chronic widesp- read musculoskeletal complaints and thyroid autoimmunity. Re- sults from a community survey. Scand J Prim Health Care. 1996 Jun;14(2):111-5. 18. Suk JH, Lee JH, Kim JM. Association between thyroid autoim- munity and fibromyalgia. Exp Clin Endocrinol Diabetes. 2012 Jul;120(7):401-4. 19. Tagoe CE, Zezon A, Khattri S. Rheumatic manifestations of auto- immune thyroid disease: the other autoimmune disease. J Rheuma- tol. 2012 Jun;39(6):1125-9. 20. Milic VD, Radunovic G, Boricic I, Ognjanovic S, Petrovic R, Radak-Perovic M, Vujasinovic-Stupar N, Damjanov N. High prevalence of autoimmune thyroid disease in subjects with sicca symptoms without Sjogren's syndrome. Rheumatology (Oxford). 2013 Apr;52(4):754-5. 21. Papanikolaou N, Perros P. An unusual presenting symptom of gra- ves' disease: myalgia. Eur Thyroid J. 2013 Jan;1(4):274-6. 22. Monzani F, Caraccio N, Siciliano G, Manca L, Murri L, Ferran- nini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab. 1997 Oct;82(10):3315-8. 23. Márquez A, Finol HJ, De Blanco MC, Adjounian H, Pulido- Méndez M. Skeletal muscle microvascular alterations in euthyroid and hypothyroid patients with autoimmune thyroid disease. J Sub- microsc Cytol Pathol. 2001 Oct;33(4):425-32. 24. Zelaya AS, Stotts A, Nader S, Moreno CA. Antithyroid peroxidase antibodies in patients with high normal range thyroid stimulating hormone. Fam Med. 2010 Feb;42(2):111-5. 25. Pamuk ON, Cakir N. The frequency of thyroid antibodies in fib- romyalgia patients and their relationship with symptoms. Clin Rheumatol. 2007 Jan;26(1):55-9. 26. Dardano A, Bazzichi L, Bombardieri S, Monzani F. Symptoms in Euthyroid Hashimoto's Thyroiditis: Is There a Role for Autoim- munity Itself? Thyroid. 2011 Dec 22. [Epub ahead of print] Pub- Med PMID: 22191404. 27. Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, Her- mann M. Hashimoto's thyroiditis affects symptom load and qua- lity of life unrelated to hypothyroidism: a prospective case-cont- rol study in women undergoing thyroidectomy for benign goiter. Thyroid. 2011 Feb;21(2):161-7. 28. Russell J, Michalek JE, Xiao Y, et al. Therapy with a central alp- ha-2 adrenergic agonist [tizanidine] decreases cerebrospinal fluid substance p, and may reduce serum hyaluronic acid as it improves the clinical symptoms of the fibromyalgia syndrome. 29. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. 30. Buskila D, Sarzi-Puttini P. Fibromyalgia and autoimmune di- seases: the pain behind autoimmunity. Isr Med Assoc J. 2008 Jan;10(1):77-8. 31. Jensen B, Wittrup IH, Wiik A, et al. Antipolymer antibodies in Da- nish fibromyalgia patients. Clin Exp Rheumatol 2004;22:227–9. 32. Smart PA, Waylonis GW, Hackshaw KV. Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil 1997;76:231–4. 33. Effectiveness and safety of T3 (triiodothyronine) therapy for euth- yroid fibromyalgia: a double-blind placebo-controlled response- driven crossover study. John C. Lowe, MA, DC, Richard L. Gar- rison, MD, Alan J. Reichman, MD, Jackie Yellin, BA, Mervianna Thompson, RN, MSN, APN, Daniel Kaufman, MD: Clinical Bul- letin of Myofascial Therapy, 2(2/3):31-58, 1997.